WorksheetsOncology Online Exam
Total questions: 20
Worksheet time: 3600secs
Dracenax contains __ mg of Letrozole.
25mg
10mg
2.5mg
5mg
Dracenax inhibits the aromatase enzyme by competitively binding to the hem of the aromatase cytochrome P450, resulting in the rapid decrease of androgen biosynthesis in all tissues where present.
True
False
What are the two landmark trials of Letrozole?
BIG 1-98, TEAM
TEAM, MA-17
MA-17, BIG 1-98
What is the product positioning of Dracenax?
For patients with HR+ postmenopausal early breast cancer.
Innovator Quality Made More Affordable
Let Her Journey Continue with Dracenax
In 12.6 years follow-up of BIG-198 Trial, patients taking Letrozole reduced the risk of distant recurrences by?
15%
20%
18%
Arostanil contains __ mg of Exemestane.
25mg
10mg
2.5 mg
What are the product deals of Arostanil?
1+1, 3+7
1+1, 4+7
1+1, 7+6
These are the most frequently reported adverse reactions of patients taking Dracenax.
hot flushes
arthralgia
bone pain
all options are correct
Dracenax is manufactured in _____.
Stein, Switzerland
Berleben, Germany
Kundel, Austria
Dracenax and Arostanil have demonstrated efficacy in patients with hormone receptor negative breast cancer.
True
False
Estrogen promotes bone calcification, thus preventing osteoporosis.
True
False
What stage of breast cancer is T1 N0 M1?
Stage 4
Stage 3b
Stage 2b
Stage 3a
Which of the following is a high risk factor for breast cancer?
Personal history of breast cancer
High dose of radiation to the chest
Obesity
DCIS has a poorer prognosis compared to inflammatory breast cancer.
True
False
Dracenax and Arostanil belong to what type of Breast Cancer therapy?
Chemotherapy
Hormonal Therapy
Immunotherapy
Chemotherapy and hormonal therapy cannot be given together as a treatment plan for Breast Cancer.
True
False
Hormonal therapy is designed to disrupt the cell cycle.
True
False
These are the strategic imperatives of Sandoz Oncology, except for one.
Establish Sandoz as a trusted partner in Oncology
Drive the value of Sandoz Oncology products
Expand access to Sandoz Oncology brands
For Dracenax to be the preferred Letrozole for HR+ post menopausal early breast cancer
What is the key message of Dracenax in 2020?
Her journey continues with Dracenax. Innovator quality made more affordable.
Closer to Patients through high quality and accessible Letrozole.
Accessible Aromatase Inhibitor, Improving the lives of HR+ postmenopausal breast cancer Filipino women.
The following are the product deals of Dracenax, except for one.
12+12
7+6
4+7
20+26
